UNSPSC 51263003: Trimazosin

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C20H29N5O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 31L760807H, chemically known as 4-(4-amino-6,7,8-trimethoxy-2-quinazolinyl)-1-piperazinecarboxylic acid, 2-hydroxy-2-methylpropyl ester but generally known as trimazosin, which bears US NIH Compound Identifier 37264. European Medicines Agency schedules Trimazosin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11298MIG.

UNSPSC 51263003 Trimazosin is a Commodity code that, based on recent state and local activity, encompasses pharmaceutical procurement for emergency medical response and community health initiatives rather than the specific drug named in the code. State and local governments buying under this code are sourcing naloxone, safe drug deactivation systems, and prescription fulfillment programs through competitive bidding and exploratory requests for information. Issuing bodies include county health departments and state human services agencies; Seminole County, Florida and the Texas Health and Human Services Commission are the principal recent buyers. The work involves quarterly delivery of medical countermeasures to fixed locations, direct-to-manufacturer prescription contracting arrangements with pharmacy benefit programs, and compliance with federal funding and workplace requirements including E-Verify and drug-free workplace certification.

Recent activity concentrates in Florida and Texas. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 and a two-year initial term plus one-year renewal option. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor intelligence on direct-to-manufacturer prescription programs for self-insured employee health plans and state agencies, with response due the same day. Neither opportunity specifies explicit set-asides for disadvantaged enterprises, though both impose standard workplace and compliance certifications.